Aperio Group’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $375M | Sell |
2,383,648
-135,387
| -5% | -$20M | 1.11% | 6 |
|
|
2020
Q3 | $375M | Buy |
2,519,035
+28,067
| +1% | +$4.15M | 1.27% | 6 |
|
|
2020
Q2 | $350M | Buy |
2,490,968
+60,875
| +3% | +$8.87M | 1.29% | 6 |
|
|
2020
Q1 | $319M | Sell |
2,430,093
-23,935
| -1% | -$3.4M | 1.41% | 5 |
|
|
2019
Q4 | $358M | Buy |
2,454,028
+261,548
| +12% | +$35.5M | 1.29% | 5 |
|
|
2019
Q3 | $284M | Sell |
2,192,480
-27,716
| -1% | -$3.65M | 1.12% | 6 |
|
|
2019
Q2 | $309M | Buy |
2,220,196
+151,473
| +7% | +$21M | 1.26% | 5 |
|
|
2019
Q1 | $289M | Buy |
2,068,723
+64,729
| +3% | +$8.67M | 1.25% | 5 |
|
|
2018
Q4 | $259M | Sell |
2,003,994
-145,533
| -7% | -$20.3M | 1.3% | 5 |
|
|
2018
Q3 | $297M | Buy |
2,149,527
+71,163
| +3% | +$9.46M | 1.31% | 5 |
|
|
2018
Q2 | $252M | Sell |
2,078,364
-137,179
| -6% | -$17.1M | 1.21% | 5 |
|
|
2018
Q1 | $284M | Buy |
2,215,543
+22,849
| +1% | +$3.09M | 1.41% | 4 |
|
|
2017
Q4 | $306M | Buy |
2,192,694
+72,436
| +3% | +$10.1M | 1.56% | 3 |
|
|
2017
Q3 | $276M | Buy |
2,120,258
+88,547
| +4% | +$11.7M | 1.56% | 3 |
|
|
2017
Q2 | $269M | Buy |
2,031,711
+118,746
| +6% | +$15.1M | 1.65% | 3 |
|
|
2017
Q1 | $238M | Buy |
1,912,965
+89,194
| +5% | +$10.7M | 1.63% | 3 |
|
|
2016
Q4 | $210M | Sell |
1,823,771
-185,506
| -9% | -$21.4M | 1.61% | 3 |
|
|
2016
Q3 | $237M | Buy |
2,009,277
+124,670
| +7% | +$15.1M | 1.72% | 2 |
|
|
2016
Q2 | $229M | Buy |
1,884,607
+133,473
| +8% | +$15.2M | 1.79% | 2 |
|
|
2016
Q1 | $189M | Buy |
1,751,134
+85,451
| +5% | +$8.85M | 1.62% | 3 |
|
|
2015
Q4 | $171M | Buy |
1,665,683
+149,399
| +10% | +$15M | 1.57% | 3 |
|
|
2015
Q3 | $142M | Buy |
1,516,284
+183,702
| +14% | +$17.8M | 1.44% | 3 |
|
|
2015
Q2 | $130M | Buy |
1,332,582
+118,086
| +10% | +$11.8M | 1.34% | 2 |
|
|
2015
Q1 | $122M | Buy |
1,214,496
+83,417
| +7% | +$8.48M | 1.37% | 2 |
|
|
2014
Q4 | $118M | Buy |
1,131,079
+114,343
| +11% | +$12M | 1.46% | 2 |
|
|
2014
Q3 | $108M | Buy |
1,016,736
+87,794
| +9% | +$9.11M | 1.46% | 3 |
|
|
2014
Q2 | $97.2M | Buy |
928,942
+73,764
| +9% | +$7.46M | 1.41% | 3 |
|
|
2014
Q1 | $84M | Buy |
+855,178
| New | +$79.3M | 1.18% | 3 |
|
|
2013
Q4 | – | Sell |
-682,334
| Closed | -$62.9M | – | 3 |
|
|
2013
Q3 | $59.2M | Buy |
682,334
+72,830
| +12% | +$6.53M | 1.14% | 3 |
|
|
2013
Q2 | $52.3M | Buy |
+609,504
| New | +$51.7M | 1.24% | 4 |
|
Other funds holding JNJ
Aperio Group's JNJ Position: Q4 2020 in Review
Aperio Group reduced its Johnson & Johnson (JNJ) stake by 5.4% in Q4 2020, selling an estimated $20M and leaving 2,383,648 shares worth $375M. The position accounts for 1.11% of the portfolio, ranked #6.
Aperio Group first reported a position in JNJ in Q2 2013 and has held it in 30 quarters since. 3,266 funds tracked by Wall St. Rank hold JNJ as of Q4 2020.
- Aperio Group held 2,383,648 shares of Johnson & Johnson worth $375M as of Q4 2020.
- Aperio Group sold 135,387 Johnson & Johnson shares in Q4 2020, an estimated $20M.
- Johnson & Johnson made up 1.11% of Aperio Group's portfolio in Q4 2020, its #6 holding.
- Aperio Group first reported a position in Johnson & Johnson in Q2 2013 and has held it in 30 quarters since.
- 3,266 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2020.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.